News

Innocoll, a biopharmaceutical company, has announced that the last patient has been dosed in the second of two ongoing US Phase III clinical trials sponsored by its wholly

Under the terms of the agreement, Morphotek will be responsible for validating targets discovered through genomic research and provided by Human Genome Sciences (HGS), generating and developing all

Excluding interest, depreciation and stock-based compensation, on a non-GAAP basis, the Company’s net income increased by over $1 million to $1.7 million for the year 2008 compared to

Molnlycke Health Care US, a manufacturer and supplier of powder-free surgical gloves, has launched Biogel brand PI Indicator Underglove, a new glove to its line that helps clinicians

Tongjitang Chinese Medicines Company, a Chinese specialty pharmaceutical company, has reported a net loss of RMB79.26m, or RMB0.59 per share, for the fourth quarter of 2008, compared to

Highlights of the fourth quarter of 2008 and recent weeks include: Introducing the company’s first three cancer diagnostic tests in the US, miRview mets, miRview squamous and miRview

Wyeth has reported that its Prevenar has been added to Saudi Arabia’s national childhood immunization program to help protect infants and young children from pneumococcal disease – said

A total of approximately 395.7 million shares of Genentech common stock were tendered representing 84.7% of Genentech’s publicly held shares. Roche Investments USA has accepted for payment all

Caldera’s products include the Desara sling system for treating stress urinary incontinence. Encision will use its sales employees to supplement Caldera’s sales team in introducing Caldera’s products to